UKNEQAS – Navigating Quality Standards in POC Testing

Event Date: October 23, 2024
Location: Hyatt Regency Birmingham

We are delighted to be attending this UKNEQAS event which will provide valuable insights into UK NEQAS and its impact on advancing POCT, as well as exploring current trends and challenges in POCT from industry experts.

We will also be taking the opportunity to provide a live demo of the SmarTest® Calprotectin Home test, showcasing the benefits and ease of use of this game changing POCT device for IBD patients.

Request a meeting

About BIOHIT HealthCare

BIOHIT HealthCare is a Finnish biotech company, headquartered in Helsinki, that specialises in the development, manufacture and distribution of kits and assays for the screening, diagnosis and monitoring of digestive diseases. Its core disease focus areas include stomach health and dyspepsia, reflux and acid dysregulation, Inflammatory Bowel Disease (IBD), functional gastrointestinal disorders (FGID), Irritable bowel syndrome (IBS), and gut microbiota dysbiosis. Innovating for Health www.biohithealthcare.co.uk

0

Recent Events

Exploring advances in TDM for IBD management: insights from our recent webinar

August 21, 2024
Unboxing of Peptest

The inside edge on Peptest for the diagnosis of silent reflux

May 20, 2024
National Well-Being

The UK’s health landscape and the endeavour for national well-being

May 10, 2024
Endoscopy in a hospital

Tackling the challenge of Helicobacter pylori in record time with the ULTRA-FAST UFT300 Quick Test

February 7, 2024